By Svea Herbst-Bayliss NEW YORK, June 9 (Reuters) – Activist Ancora Alternatives has built a significant stake in Ashland Inc and wants the U.S. specialty chemicals company to sell itself, arguing
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)